BCBHF yields 71124681.52% · PFE yields 6.20%● Live data
📍 BCBHF pulled ahead of the other in Year 1
Combined, BCBHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCBHF + PFE for your $10,000?
Caribbean Investment Holdings Limited, through its subsidiaries, provides various banking, financial, and related services to individual and corporate customers primarily in Belize. The company offers lending, savings and merchant accounts, term deposits, and non-interest bearing and interest-bearing checking accounts; and credit and debit cards, as well as payment processing services to merchants. It also provides credit facilities that include overdrafts, lines of credit, and secured mortgage loans for personal, residential, or commercial purposes; and financial instruments, including commitments to extend credit, standby letters of credit, and financial guarantees. In addition, the company offers corporate services for its clients, such as virtual office, bookkeeping, and shipping agent services, as well as company formation and administration services. It operates a network of eleven branches and 28 ATMs, as well as 1,200 point of sale terminals. The company was formerly known as BCB Holdings Limited and changed its name to Caribbean Investment Holdings Limited in December 2015. Caribbean Investment Holdings Limited is headquartered in Providenciales, Turks and Caicos.
Full BCBHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.